L. H. Reddy, J. L. Arias, J. Nicolas, and P. Couvreur, Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications, Chemical Reviews, vol.112, issue.11, p.5818, 2012.
DOI : 10.1021/cr300068p

S. H. Medina and M. E. Sayed, Dendrimers as Carriers for Delivery of Chemotherapeutic Agents, Chemical Reviews, vol.109, issue.7, p.3141, 2009.
DOI : 10.1021/cr900174j

R. K. Tekade, P. V. Kumar, and N. K. Jain, Dendrimers in Oncology: An Expanding Horizon, Chemical Reviews, vol.109, issue.1, p.49, 2008.
DOI : 10.1021/cr068212n

O. C. Farokhzad, J. Cheng, B. A. Teply, I. Sherifi, S. Jon et al., Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo, Proceedings of the National Academy of Sciences, vol.103, issue.16, p.6315, 2006.
DOI : 10.1073/pnas.0601755103

O. C. Farokhzad, S. Jon, A. Khademhosseini, T. T. Tran, D. A. Lavan et al., Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells, Cancer Research, vol.64, issue.21, p.7668, 2004.
DOI : 10.1158/0008-5472.CAN-04-2550

N. Kolishetti, S. Dhar, P. M. Valencia, L. Q. Lin, R. Karnik et al., Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy, Proceedings of the National Academy of Sciences, vol.107, issue.42, p.17939, 2010.
DOI : 10.1073/pnas.1011368107

A. Albert, Chemical Aspects of Selective Toxicity, Nature, vol.127, issue.4633, p.421, 1958.
DOI : 10.1038/182421a0

E. L. Vodovozova, D. V. Evdokimov, and J. G. Molotkovsky, Synthesis of a Lipid Derivative of the Antitumor Agent Methotrexate, Russian Journal of Bioorganic Chemistry, vol.30, issue.6, p.599, 2004.
DOI : 10.1023/B:RUBI.0000049779.60159.c5

D. S. Gesto, N. M. Cerqueira, P. A. Fernandes, and M. J. Ramos, Gemcitabine: A Critical Nucleoside for Cancer Therapy, Current Medicinal Chemistry, vol.19, issue.7, p.1076
DOI : 10.2174/092986712799320682

D. B. Longley, D. P. Harkin, and P. G. Johnston, 5-Fluorouracil: mechanisms of action and clinical strategies, Nature Reviews Cancer, vol.3, issue.5, p.330, 2003.
DOI : 10.1038/nrc1074

G. A. Koning, J. A. Kamps, and G. L. Scherphof, Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes, Cancer Detection and Prevention, vol.26, issue.4, p.299, 2002.
DOI : 10.1016/S0361-090X(02)00087-9

C. I. Hong, A. J. Kirisits, A. Nechaev, and D. Buchheit, Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-.beta.-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids, Journal of Medicinal Chemistry, vol.33, issue.5, p.1380, 1990.
DOI : 10.1021/jm00167a016

Y. Tokunaga, T. Iwasa, J. Fujisaki, S. Sawai, and A. Kagayama, Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-.BETA.-D-arabinofuranosylcytosine prodrug-bearing liposomes., CHEMICAL & PHARMACEUTICAL BULLETIN, vol.36, issue.9, p.3574, 1988.
DOI : 10.1248/cpb.36.3574

M. L. Immordino, P. Brusa, F. Rocco, S. Arpicco, M. Ceruti et al., Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs, Journal of Controlled Release, vol.100, issue.3, p.331, 2004.
DOI : 10.1016/j.jconrel.2004.09.001

F. Castelli, M. G. Sarpietro, M. Ceruti, F. Rocco, and L. Cattel, Characterization of Lipophilic Gemcitabine Prodrug???Liposomal Membrane Interaction by Differential Scanning Calorimetry, Molecular Pharmaceutics, vol.3, issue.6, p.737, 2006.
DOI : 10.1021/mp060059y

Y. Jin, Y. Lian, and L. Du, Self-assembly of N-acyl derivatives of gemcitabine at the air/water interface and the formation of nanoscale structures in water, Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol.393, p.60, 2012.
DOI : 10.1016/j.colsurfa.2011.11.001

W. G. Chung, M. A. Sandoval, B. R. Sloat, P. D. Lansakara, and . Cui, Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1, Journal of Controlled Release, vol.157, issue.1, p.132, 2012.
DOI : 10.1016/j.jconrel.2011.08.004

L. H. Reddy, C. Dubernet, S. L. Mouelhi, P. E. Marque, D. Desmaele et al., A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types, Journal of Controlled Release, vol.124, issue.1-2, p.20, 2007.
DOI : 10.1016/j.jconrel.2007.08.018

L. H. Reddy, H. Khoury, A. Paci, A. Deroussent, H. Ferreira et al., Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice, Drug Metabolism and Disposition, vol.36, issue.8, p.1570, 2008.
DOI : 10.1124/dmd.108.020735

P. Couvreur, Anti-Cancer Drugs, p.999, 2008.

O. C. Farokhzad and R. Langer, Impact of Nanotechnology on Drug Delivery, ACS Nano, vol.3, issue.1, p.16, 2009.
DOI : 10.1021/nn900002m

A. Albert, Chemical Aspects of Selective Toxicity, Nature, vol.127, issue.4633, p.421, 1958.
DOI : 10.1038/182421a0

J. Kope?ek, P. Kope?ková, and . Adv, HPMA copolymers: Origins, early developments, present, and future???, Advanced Drug Delivery Reviews, vol.62, issue.2, p.122, 2010.
DOI : 10.1016/j.addr.2009.10.004

R. Duncan, Polymer conjugates as anticancer nanomedicines, Nature Reviews Cancer, vol.54, issue.9, p.688, 2006.
DOI : 10.1038/nrc1958

M. J. Vicent and R. Duncan, Polymer conjugates: nanosized medicines for treating cancer, Trends in Biotechnology, vol.24, issue.1, p.39, 2006.
DOI : 10.1016/j.tibtech.2005.11.006

R. Tong and J. Cheng, Ring-Opening Polymerization-Mediated Controlled Formulation of Polylactide???Drug Nanoparticles, Journal of the American Chemical Society, vol.131, issue.13, p.4744, 2009.
DOI : 10.1021/ja8084675

S. Harrisson, J. Nicolas, A. Maksimenko, D. T. Bui, J. Mougin et al., Nanoparticles with In???Vivo Anticancer Activity from Polymer Prodrug Amphiphiles Prepared by Living Radical Polymerization, Angewandte Chemie International Edition, vol.43, issue.6, p.1678, 2013.
DOI : 10.1002/anie.201207297
URL : https://hal.archives-ouvertes.fr/hal-01325213

T. Nguyen and M. B. Francis, Practical Synthetic Route to Functionalized Rhodamine Dyes, Organic Letters, vol.5, issue.18, p.3245, 2003.
DOI : 10.1021/ol035135z

E. S. Lee, K. Na, and Y. H. Bae, Super pH-Sensitive Multifunctional Polymeric Micelle, Nano Letters, vol.5, issue.2, p.325, 2005.
DOI : 10.1021/nl0479987

H. Hillaireau and P. Couvreur, Nanocarriers??? entry into the cell: relevance to drug delivery, Cellular and Molecular Life Sciences, vol.31, issue.Suppl 1, p.2873, 2009.
DOI : 10.1007/s00018-009-0053-z

M. L. Hans and A. M. Lowman, Biodegradable nanoparticles for drug delivery and targeting, Current Opinion in Solid State and Materials Science, vol.6, issue.4, p.319, 2002.
DOI : 10.1016/S1359-0286(02)00117-1

J. Wang, W. Liu, Q. Tu, J. Wang, N. Song et al., Folate-Decorated Hybrid Polymeric Nanoparticles for Chemically and Physically Combined Paclitaxel Loading and Targeted Delivery, Biomacromolecules, vol.12, issue.1, p.228, 2010.
DOI : 10.1021/bm101206g

V. T. Huynh, G. Chen, and P. Souza, Thiol???yne and Thiol???ene ???Click??? Chemistry as a Tool for a Variety of Platinum Drug Delivery Carriers, from Statistical Copolymers to Crosslinked Micelles, Biomacromolecules, vol.12, issue.5, p.1738, 2011.
DOI : 10.1021/bm200135e

V. T. Huynh, P. De-souza, and M. H. Stenzel, -Platinum Drug Delivery, Macromolecules, vol.44, issue.20, p.7888, 2011.
DOI : 10.1021/ma2016503
URL : https://hal.archives-ouvertes.fr/hal-00109780

X. Chen, S. S. Parelkar, E. Henchey, S. Schneider, and T. Emrick, PolyMPC???Doxorubicin Prodrugs, Bioconjugate Chemistry, vol.23, issue.9, p.1753, 2012.
DOI : 10.1021/bc200667s

Q. Yin, R. Tong, Y. Xu, K. Baek, L. W. Dobrucki et al., -carboxyanhydride) Nanoconjugates, Biomacromolecules, vol.14, issue.3, p.920, 2013.
DOI : 10.1021/bm301999c
URL : https://hal.archives-ouvertes.fr/hal-01358925

H. Yang, J. Silverman, and J. J. Wozniak, Low temperature heat shrinkable polymer material, p.4596728, 1986.

S. Tanuma, C. J. Powell, and D. R. Penn, Calculations of electron inelastic mean free paths. V. Data for 14 organic compounds over the 50-2000 eV range, Surface and Interface Analysis, vol.20, issue.3, p.165, 1994.
DOI : 10.1002/sia.740210302

I. Bertholon, C. Vauthier, and D. Labarre, Complement Activation by Core???Shell Poly(isobutylcyanoacrylate)???Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide, Pharmaceutical Research, vol.17, issue.6, p.1313, 2006.
DOI : 10.1007/s11095-006-0069-0

M. D. Kazatchkine and M. Carreno, Activation of the complement system at the interface between blood and artificial surfaces, Biomaterials, vol.9, issue.1, p.30, 1988.
DOI : 10.1016/0142-9612(88)90066-X

C. Boyer, V. Bulmus, T. P. Davis, V. Ladmiral, J. Liu et al., Bioapplications of RAFT Polymerization, Chemical Reviews, vol.109, issue.11, p.5402, 2009.
DOI : 10.1021/cr9001403

O. C. Farokhzad and R. Langer, Impact of Nanotechnology on Drug Delivery, ACS Nano, vol.3, issue.1, p.16, 2009.
DOI : 10.1021/nn900002m

A. Albert, Chemical Aspects of Selective Toxicity, Nature, vol.127, issue.4633, p.421, 1958.
DOI : 10.1038/182421a0

T. Schluep, J. Hwang, J. Cheng, J. D. Heidel, D. W. Bartlett et al., Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models, Clinical Cancer Research, vol.12, issue.5, p.1606, 2006.
DOI : 10.1158/1078-0432.CCR-05-1566

X. Chen, S. S. Parelkar, E. Henchey, S. Schneider, and T. Emrick, PolyMPC???Doxorubicin Prodrugs, Bioconjugate Chemistry, vol.23, issue.9, p.1753, 2012.
DOI : 10.1021/bc200667s

M. J. Vicent and R. Duncan, Polymer conjugates: nanosized medicines for treating cancer, Trends in Biotechnology, vol.24, issue.1, p.39, 2006.
DOI : 10.1016/j.tibtech.2005.11.006

R. Duncan, Polymer conjugates as anticancer nanomedicines, Nature Reviews Cancer, vol.54, issue.9, p.688, 2006.
DOI : 10.1038/nrc1958

D. Putnam and J. Kope?ek, Polymer conjugates with anticancer activity Biopolymers II, p.55, 1995.

C. J. Hawker, A. W. Bosman, and E. Harth, New Polymer Synthesis by Nitroxide Mediated Living Radical Polymerizations, Chemical Reviews, vol.101, issue.12, p.3661, 2001.
DOI : 10.1021/cr990119u

R. B. Grubbs, Nitroxide-Mediated Radical Polymerization: Limitations and Versatility, Polymer Reviews, vol.19, issue.2, p.104, 2011.
DOI : 10.1002/mren.200800015

M. Kamigaito, T. Ando, and M. Sawamoto, Metal-Catalyzed Living Radical Polymerization, Chemical Reviews, vol.101, issue.12, p.3689, 2001.
DOI : 10.1021/cr9901182

C. Boyer, V. Bulmus, T. P. Davis, V. Ladmiral, J. Liu et al., Bioapplications of RAFT Polymerization, Chemical Reviews, vol.109, issue.11, p.5402, 2009.
DOI : 10.1021/cr9001403

K. L. Heredia and H. D. Maynard, Synthesis of protein???polymer conjugates, Org. Biomol. Chem., vol.43, issue.1, p.45, 2007.
DOI : 10.1039/B612355D

C. Cheng, K. Qi, E. Khoshdel, and K. L. Wooley, Tandem Synthesis of Core???Shell Brush Copolymers and Their Transformation to Peripherally Cross-Linked and Hollowed Nanostructures, Journal of the American Chemical Society, vol.128, issue.21, p.6808, 2006.
DOI : 10.1021/ja061892r

H. Yang, J. Silverman, and J. J. Wozniak, Low temperature heat shrinkable polymer material, p.4596728, 1986.

C. M. Galmarini, J. R. Mackey, and C. Dumontet, Nucleoside analogues: mechanisms of drug resistance and reversal strategies, Leukemia, vol.15, issue.6, p.875, 2001.
DOI : 10.1038/sj.leu.2402114

J. Nicolas and . Macromolecules, 13 C NMR: (CDCl 3 , 75 MHz): Major diastereomer: ? 171, p.9291, 2010.

. Hz, 8 (C g , d, 2 J C-P = 4.2 Hz), pp.25-31

. Csi, 3 (C i,j , d, 3 J C-P = 6.6 Hz), -5, Si(CH 3 ) 2 ) ppm

. Hz-)-ppm, Minor diastereomer: ? -115.6, -113, AB' system, 2 J F-F = 239 Hz) ppm

L. H. Reddy and P. Couvreur, Novel Approaches to Deliver Gemcitabine to Cancers, Current Pharmaceutical Design, vol.14, issue.11, p.1124, 2008.
DOI : 10.2174/138161208784246216

P. Couvreur, Anti-Cancer Drugs, p.999, 2008.

H. Yang, J. Silverman, and J. J. Wozniak, Low temperature heat shrinkable polymer material, p.4596728, 1986.